Harvard Apparatus Regenerative Technology, Inc. SEC filings HRGN

Harvard Apparatus Regenerative Technology, Inc. has 625 filings in SEC EDGAR's recent list, going back to Dec 11, 2012. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Harvard Apparatus Regenerative Technology, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Sep 25, 2026 Sep 11, 2026
8-K Current report
Material agreement, Unregistered share sale
Sep 14, 2026 Sep 11, 2026
D Filing Sep 14, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
4 Insider transaction Aug 11, 2026 Jul 21, 2026
8-K Current report
Material agreement, New debt
Aug 3, 2026 May 8, 2026
8-K/A Amended current report
Material agreement, New debt
Aug 3, 2026 Apr 13, 2026
8-K Current report
Shareholder vote results
Jun 24, 2026 Jun 18, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
Apr 28, 2026 Apr 27, 2026
DEF 14A Proxy statement Apr 23, 2026 Jun 18, 2026
8-K Current report
Agreement ended
Apr 15, 2026 Apr 13, 2026
10-K Annual report Mar 19, 2026 Dec 31, 2025
D Filing Jan 6, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jan 6, 2026 Dec 30, 2025
4 Insider transaction Dec 1, 2025 Nov 25, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Sep 24, 2025 Sep 2, 2025
4 Insider transaction Sep 2, 2025 Aug 21, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
D Filing Jul 14, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Jul 14, 2025 Jul 11, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
8-K Current report
Shareholder vote results
Jun 24, 2025 Jun 20, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
DEF 14A Proxy statement Apr 29, 2025 Jun 20, 2025
PRE 14A Preliminary proxy statement Apr 17, 2025 Jun 20, 2025
8-K Current report
Auditor change
Apr 14, 2025 Apr 11, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
CORRESP Letter to the SEC Jan 6, 2025 —
4 Insider transaction Jan 2, 2025 Dec 24, 2024
UPLOAD Letter from the SEC Dec 12, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Material agreement
Nov 6, 2024 Oct 31, 2024
4 Insider transaction Sep 26, 2024 Sep 3, 2024
3 Initial insider ownership Sep 26, 2024 Aug 26, 2024
SC 13D Ownership over 5% (active) Sep 26, 2024 —
4 Insider transaction Sep 12, 2024 Aug 27, 2024
8-K Current report
Officer or director change
Aug 27, 2024 Aug 26, 2024
8-K Current report
Material agreement, Unregistered share sale
Aug 21, 2024 Aug 19, 2024
SC 13D/A Amended ownership over 5% (active) Aug 16, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
4 Insider transaction Aug 7, 2024 Jul 8, 2024
D Filing Aug 6, 2024 —
4 Insider transaction Jul 15, 2024 Jun 27, 2024
4 Insider transaction Jul 15, 2024 Jun 27, 2024
4 Insider transaction Jul 15, 2024 Jun 27, 2024
4 Insider transaction Jul 15, 2024 Jun 27, 2024
4 Insider transaction Jul 15, 2024 Jun 27, 2024
4 Insider transaction Jul 15, 2024 Jun 27, 2024
4 Insider transaction Jul 2, 2024 Jun 21, 2024
8-K Current report
Shareholder vote results
Jun 24, 2024 Jun 20, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
DEF 14A Proxy statement Apr 29, 2024 Apr 29, 2024
8-K Current report
Material agreement, Unregistered share sale
Apr 17, 2024 Apr 15, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
8-K Current report
Material agreement, New debt
Feb 6, 2024 Feb 1, 2024
4 Insider transaction Jan 12, 2024 Jan 11, 2024
4 Insider transaction Jan 3, 2024 Dec 27, 2023
4 Insider transaction Dec 18, 2023 Dec 14, 2023
4 Insider transaction Dec 11, 2023 Dec 6, 2023
S-8 Employee stock plan registration Nov 16, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
4 Insider transaction Sep 18, 2023 Sep 11, 2023
4 Insider transaction Sep 5, 2023 Aug 28, 2023
4 Insider transaction Aug 28, 2023 Aug 18, 2023
4 Insider transaction Aug 23, 2023 Aug 21, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
4 Insider transaction Jul 28, 2023 Jul 26, 2023
4 Insider transaction Jul 28, 2023 Jul 26, 2023
4 Insider transaction Jul 28, 2023 Jul 26, 2023
4 Insider transaction Jul 28, 2023 Jul 26, 2023
4 Insider transaction Jul 28, 2023 Jul 26, 2023
4 Insider transaction Jul 28, 2023 Jul 26, 2023
8-K Current report
Bylaw or fiscal year change, Other events
Jul 20, 2023 Jul 20, 2023
8-K Current report
Shareholder vote results
Jul 19, 2023 Jul 19, 2023
4/A Filing Jul 10, 2023 Apr 10, 2023
8-K/A Amended current report
Unregistered share sale, Officer or director change
Jul 10, 2023 Jul 10, 2023
DEFR14A Filing Jun 7, 2023 —
DEFA14A Additional proxy material Jun 7, 2023 —
DEF 14A Proxy statement Jun 5, 2023 Jun 5, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
4 Insider transaction May 2, 2023 Apr 12, 2023
3 Initial insider ownership May 2, 2023 Apr 5, 2023
D Filing Apr 14, 2023 —
4 Insider transaction Apr 12, 2023 Apr 10, 2023
4 Insider transaction Apr 10, 2023 Apr 6, 2023
8-K Current report
Officer or director change
Apr 10, 2023 Apr 5, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 6, 2023 Mar 31, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Unregistered share sale, Officer or director change
Mar 14, 2023 Mar 14, 2023
8-K Current report
Material agreement, Officer or director change, Other events
Mar 7, 2023 Mar 1, 2023
4 Insider transaction Mar 2, 2023 Feb 28, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2023 —
RW Filing Feb 1, 2023 —
4 Insider transaction Jan 27, 2023 Jan 25, 2023
8-K Current report
Unregistered share sale, Officer or director change
Jan 26, 2023 Jan 25, 2023
8-K Current report
Unregistered share sale, Officer or director change
Jan 12, 2023 Jan 11, 2023
4 Insider transaction Jan 5, 2023 Dec 12, 2022
8-K Current report
Other events
Dec 28, 2022 Dec 28, 2022
8-K Current report
Other events
Dec 23, 2022 Dec 23, 2022
4 Insider transaction Dec 9, 2022 Dec 7, 2022
4 Insider transaction Dec 9, 2022 Dec 7, 2022
4 Insider transaction Dec 9, 2022 Dec 7, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
S-1/A Amended registration statement Oct 27, 2022 —
8-K Current report
Auditor change
Oct 12, 2022 Oct 10, 2022
8-K/A Amended current report
Shareholder vote results
Sep 20, 2022 Jun 22, 2022
8-K Current report
Officer or director change
Aug 10, 2022 Aug 8, 2022
4 Insider transaction Aug 9, 2022 Aug 8, 2022
3 Initial insider ownership Aug 9, 2022 Aug 8, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Shareholder vote results
Aug 2, 2022 Jul 28, 2022
DEF 14A Proxy statement Jul 5, 2022 Jul 28, 2022
4 Insider transaction Jul 1, 2022 Jun 29, 2022
4 Insider transaction Jul 1, 2022 Jun 29, 2022
4 Insider transaction Jul 1, 2022 Jun 29, 2022
4 Insider transaction Jul 1, 2022 Jun 29, 2022
4 Insider transaction Jul 1, 2022 Jun 29, 2022
PRE 14A Preliminary proxy statement Jun 23, 2022 Jul 28, 2022
8-K Current report
Shareholder vote results
Jun 22, 2022 Jun 22, 2022
S-1 Registration statement Jun 21, 2022 —
SC 13G Ownership over 5% (passive) Jun 21, 2022 —
8-K Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Jun 13, 2022 Jun 10, 2022
D Filing Jun 8, 2022 —
4 Insider transaction May 23, 2022 May 12, 2022
4 Insider transaction May 23, 2022 May 12, 2022
4 Insider transaction May 20, 2022 May 18, 2022
4 Insider transaction May 20, 2022 May 18, 2022
4 Insider transaction May 19, 2022 May 12, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Material agreement, Unregistered share sale
May 13, 2022 May 12, 2022
DEFA14A Additional proxy material May 2, 2022 —
DEF 14A Proxy statement May 2, 2022 Jun 22, 2022
8-K Current report
Material agreement, Other events
Apr 28, 2022 Apr 27, 2022
8-K Current report
Results of operations
Apr 1, 2022 Apr 1, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
8-K Current report
Other events
Feb 3, 2022 Feb 3, 2022
8-K Current report
Other events
Jan 27, 2022 Jan 25, 2022
4 Insider transaction Jan 3, 2022 Dec 29, 2021
4 Insider transaction Jan 3, 2022 Dec 29, 2021
8-K Current report
Regulation FD disclosure
Dec 6, 2021 Dec 6, 2021
4 Insider transaction Nov 30, 2021 Nov 26, 2021
3 Initial insider ownership Nov 30, 2021 Nov 26, 2021
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
Nov 30, 2021 Nov 26, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
4 Insider transaction Nov 10, 2021 Sep 5, 2021
4 Insider transaction Nov 10, 2021 Jul 1, 2021
4 Insider transaction Nov 10, 2021 Jul 1, 2021
4 Insider transaction Nov 10, 2021 Jul 1, 2021
4 Insider transaction Nov 10, 2021 Jul 1, 2021
3 Initial insider ownership Nov 10, 2021 Sep 1, 2021
8-K Current report
Other events
Sep 24, 2021 Sep 15, 2021
SC 13G Ownership over 5% (passive) Sep 23, 2021 —
D/A Filing Sep 10, 2021 —
SC 13D/A Amended ownership over 5% (active) Sep 10, 2021 —
4 Insider transaction Sep 9, 2021 Sep 1, 2021
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
Sep 8, 2021 Sep 1, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 13, 2021 Aug 13, 2021
8-K Current report
Auditor change
Jul 9, 2021 Jul 6, 2021
8-K Current report
Shareholder vote results
Jun 28, 2021 Jun 24, 2021
8-K Current report
Other events
Jun 24, 2021 Jun 24, 2021
D Filing Jun 23, 2021 —
SC 13D/A Amended ownership over 5% (active) Jun 23, 2021 —
8-K Current report
Material agreement, Unregistered share sale
Jun 22, 2021 Jun 17, 2021
4 Insider transaction Jun 21, 2021 Jun 17, 2021
8-K Current report
Auditor change
May 27, 2021 May 25, 2021
10-Q Quarterly report May 24, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 24, 2021 May 24, 2021
NT 10-Q Filing May 17, 2021 Mar 31, 2021
3 Initial insider ownership May 4, 2021 Apr 8, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 24, 2021
10-K Annual report Apr 13, 2021 Dec 31, 2020
8-K Current report
Results of operations, Officer or director change
Apr 13, 2021 Apr 8, 2021
NT 10-K Form 12b-25 Mar 31, 2021 Dec 30, 2020
8-K Current report
Officer or director change
Feb 19, 2021 Feb 15, 2021
8-K Current report
Officer or director change
Feb 4, 2021 Jan 29, 2021
4 Insider transaction Feb 1, 2021 Jan 26, 2021
3 Initial insider ownership Feb 1, 2021 Jan 19, 2021
8-K Current report
Officer or director change
Jan 25, 2021 Jan 19, 2021
8-K Current report
Other events
Dec 31, 2020 Dec 30, 2020
10-Q Quarterly report Nov 13, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 13, 2020 Nov 13, 2020
3 Initial insider ownership Nov 6, 2020 Oct 29, 2020
8-K Current report
Officer or director change
Oct 30, 2020 Oct 29, 2020
8-K Current report
Unregistered share sale, Other events
Oct 2, 2020 Sep 29, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
HRGN (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Holliston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1563665
Former names
Biostage, Inc. (until Jul 10, 2023)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.